Several studies have investigated the association between the GHRL rs26311, rs27647, rs696217, and rs34911341 polymorphisms with the risk of various diseases such as obesity [25], metabolic syndrome [27, 28], type 2 diabetes [29], breast cancer [30], and colorectal cancer [31]. This evidence concerns the gene GHRL and breast carcinoma.